Home

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Antibodies

Chemical Structure Cat. No. Product Name CAS No.
Mepolizumab Chemical Structure
BCP13785 Mepolizumab 196078-29-2
Mepolizumab is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma.
Bimekizumab Chemical Structure
BCP30093 Bimekizumab 1418205-77-2
Bimekizumab is a monoclonal antibody that is being investigated for ankylosing spondylitis and psoriasis.
Romosozumab Chemical Structure
BCP29946 Romosozumab 909395-70-6
Romosozumab is a humanized monoclonal antibody against sclerostin, an inhibitor of osteoblastic activity.
Obinutuzumab Chemical Structure
BCP25211 Obinutuzumab 949142-50-1
Obinutuzumab (called afutuzumab until 2009,originally GA101) is a humanized anti-CD20 monoclonal antibody as a cancer treatment.
Secukinumab Chemical Structure
BCP26257 Secukinumab 875356-43-7
Secukinumab is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A.
Daratumumab Chemical Structure
BCP23828 Daratumumab 945721-28-8
Daratumumab is an IgG1k monoclonal antibody directed against CD38.
Blinatumomab Chemical Structure
BCP28744 Blinatumomab 853426-35-4
Blinatumomab specifically targets the CD19 antigen present on B cells.
Nimotuzumab Chemical Structure
BCP25910 Nimotuzumab 828933-51-3;780758-10-3
Nimotuzumab is a humanized monoclonal antibody and binds with optimal affinity and high specificity to the extracellular region of EGFR (epidermal growth factor receptor).
Adecatumumab Chemical Structure
BCP29455 Adecatumumab 503605-66-1
Adecatumumab is a recombinant human IgG1 monoclonal antibody which is used to target tumor cells.
Ipilimumab Chemical Structure
BCP25419 Ipilimumab 477202-00-9
Ipilimumab is a monoclonal antibody that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system.
123下一页末页共 39 条记录 1 / 4 页 
0086-15971444841